Pharmaceutical Manufacturing Generics Industry Analysis

Biocon not to rush generic semaglutide to packed India market, says incoming CEO Shreehas Tambe

Biocon delays semaglutide launch in India, pivoting to global markets and innovation-driven growth strategy

Impact: 5/10